Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Nanoscope to Moderate Discussions at the 4th Annual Gene Therapy Comparability Summit | ||
By: PR Newswire Association LLC. - 14 Feb 2024 | Back to overview list |
|
DALLAS, Feb. 14, 2024 /PRNewswire/ -- Nanoscope Therapeutics, Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases, is pleased to announce its role at the 4th Annual Gene Therapy Comparability Summit taking place February 13-15, 2024, in Boston. This year's summit will focus on implementing effective comparability studies to overcome strategic and technical hurdles and expedite the approvals of novel gene therapies. Samarendra Mohanty, PhD, President and Chief Scientific Officer of Nanoscope, will chair the event. In his presentation and in a session, Dr. Mohanty will offer insights into navigating process modifications and forward-thinking strategies in transitioning to commercially viable processes while ensuring comparability. Presentation details are as follows: Session: Innovations in Gene Therapy Process Development to Aid Comparability Session: Delving into Analytical Challenges to Overcome Comparability Issues Nanoscope remains committed to pushing the boundaries of gene therapy to elevate patient outcomes and eagerly anticipates stimulating discussions with esteemed peers at this meeting. For further details and to register, visit https://genetherapy-comparability.com/ About Nanoscope Therapeutics, Inc. Investor Contact: View original content to download multimedia:https://www.prnewswire.com/news-releases/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit-302061344.html SOURCE Nanoscope Therapeutics |
||
|
||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |